Ghassan S. Kiwan

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Jean‐Claude Tardif, Simon Kouz, David D. Waters et al. · New England Journal of Medicine · 2019 · 3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

2024 ESC Guidelines for the management of elevated blood pressure and hypertension

John W. McEvoy, Cian P. McCarthy, Rosa María Bruno et al. · European Heart Journal · 2024 · 2K citations · Full text

Medicine, Cardiology, Internal Medicine +14

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Piotr Ponikowski, Bridget‐Anne Kirwan, Stefan D. Anker et al. · The Lancet · 2020 · 761 citations · Full text

Medicine, Cardiology, Iron Metabolism Disorders +11

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Nadia Bouabdallaoui, Jean‐Claude Tardif, David D. Waters et al. · European Heart Journal · 2020 · 313 citations · Full text

Medicine, Cardiology, Pharmacology +13

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Medicine, Cardiology, Pharmacotherapy +17